APA citiranje

Fowler, N. H., Davis, R. E., Rawal, S., Nastoupil, L., Hagemeister, F. B., McLaughlin, P., . . . Neelapu, S. S. (2014). Safety, activity, and immune effects of lenalidomide and rituximab in untreated indolent lymphoma. Lancet Oncol.

Citação norma Chicago

Fowler, Nathan H., et al. "Safety, Activity, and Immune Effects of Lenalidomide and Rituximab in Untreated Indolent Lymphoma." Lancet Oncol 2014.

MLA citiranje

Fowler, Nathan H., et al. "Safety, Activity, and Immune Effects of Lenalidomide and Rituximab in Untreated Indolent Lymphoma." Lancet Oncol 2014.